Prognostic value of serum CA-125 in patients with advanced epithelial ovarian cancer followed by complete remission after adjuvant chemotherapy
Obstetrics & Gynecology Science
;
: 29-35, 2013.
Article
in English
| WPRIM
| ID: wpr-170622
ABSTRACT
OBJECTIVE:
The aim of this study was to evaluate the prognostic value of serum CA-125 in advanced epithelial ovarian cancer with complete remission after primary adjuvant chemotherapy.METHODS:
We reviewed the records of 120 patients with advanced epithelial ovarian cancer who underwent primary surgery followed by adjuvant therapy at our institution between January 1998 and December 2005.RESULTS:
The median progression free survival was 21.6 months and 12.5 months in patients with nadir CA-125 levels 35 U/mL, respectively, after first cycle of adjuvant chemotherapy.CONCLUSION:
Serum CA-125 level after the first cycle of adjuvant chemotherapy is a strong independent prognostic factor for advanced epithelial ovarian cancer with complete response.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Ovarian Neoplasms
/
ROC Curve
/
Chemotherapy, Adjuvant
/
Neoplasms, Glandular and Epithelial
/
Disease-Free Survival
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Obstetrics & Gynecology Science
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS